Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-28
DOI
10.1038/s41598-017-16928-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
- (2017) Daniel E. Meyers et al. Frontiers in Oncology
- Generation and characterization of a human–mouse chimeric antibody against the extracellular domain of claudin-1 for cancer therapy using a mouse model
- (2016) Yosuke Hashimoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
- (2015) Anne Bertrand et al. BMC Medicine
- Talimogene Laherparepvec: First Global Approval
- (2015) Sarah L. Greig DRUGS
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response
- (2015) Katharina M. Uhlig et al. JOURNAL OF VIROLOGY
- A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
- (2015) Anna H. Malczyk et al. JOURNAL OF VIROLOGY
- Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial
- (2015) Katrin Ramsauer et al. LANCET INFECTIOUS DISEASES
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6
- (2015) Christiane R. Stadler et al. OncoImmunology
- T-cell receptor transfer into human T cells with ecotropic retroviral vectors
- (2014) L Koste et al. GENE THERAPY
- Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
- (2014) Patrick Micke et al. INTERNATIONAL JOURNAL OF CANCER
- Live-Attenuated Measles Virus Vaccine Targets Dendritic Cells and Macrophages in Muscle of Nonhuman Primates
- (2014) Linda J. Rennick et al. JOURNAL OF VIROLOGY
- Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy
- (2014) Stephen J. Russell et al. MAYO CLINIC PROCEEDINGS
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Prevention of Intestinal Allergy in Mice by rflaA:Ova Is Associated with Enforced Antigen Processing and TLR5-Dependent IL-10 Secretion by mDC
- (2014) Stefan Schülke et al. PLoS One
- Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells
- (2013) J.-B. Guillerme et al. CLINICAL CANCER RESEARCH
- Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine
- (2013) Christian Grossardt et al. HUMAN GENE THERAPY
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms
- (2013) Stefan Wöll et al. INTERNATIONAL JOURNAL OF CANCER
- DARPin-targeting of Measles Virus: Unique Bispecificity, Effective Oncolysis, and Enhanced Safety
- (2013) Katrin Friedrich et al. MOLECULAR THERAPY
- Maraba Virus as a Potent Oncolytic Vaccine Vector
- (2013) Jonathan G Pol et al. MOLECULAR THERAPY
- New viruses for cancer therapy: meeting clinical needs
- (2013) Tanner S. Miest et al. NATURE REVIEWS MICROBIOLOGY
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells
- (2013) Uri Ben-David et al. Nature Communications
- Systemic Combination Virotherapy for Melanoma with Tumor Antigen-Expressing Vesicular Stomatitis Virus and Adoptive T-cell Transfer
- (2012) D. M. Rommelfanger et al. CANCER RESEARCH
- Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas
- (2012) Tetsuo Ushiku et al. HISTOPATHOLOGY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Highly Specific Auto-Antibodies against Claudin-18 Isoform 2 Induced by a Chimeric HBcAg Virus-Like Particle Vaccine Kill Tumor Cells and Inhibit the Growth of Lung Metastases
- (2011) Thorsten Klamp et al. CANCER RESEARCH
- Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
- (2011) Timothy Kottke et al. NATURE MEDICINE
- In Vivo Tropism of Attenuated and Pathogenic Measles Virus Expressing Green Fluorescent Protein in Macaques
- (2010) R. D. de Vries et al. JOURNAL OF VIROLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
- (2009) Byram W Bridle et al. MOLECULAR THERAPY
- A Claudin-9–Based Ion Permeability Barrier Is Essential for Hearing
- (2009) Yoko Nakano et al. PLoS Genetics
- Measles Virus Induces Oncolysis of Mesothelioma Cells and Allows Dendritic Cells to Cross-Prime Tumor-Specific CD8 Response
- (2008) A. Gauvrit et al. CANCER RESEARCH
- Targeted Cell Entry of Lentiviral Vectors
- (2008) Sabrina Funke et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started